Alex Bard is Director at Hims & Hers Health, Inc. (HIMS). They have made 1 open-market trade across 1 company since 2023, most recently 2024-06-06.
CIK 0001837803
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| HIMS | 74,750 | $2.1M |
Shares reported on the most recent Form 4, priced at the 2024-06-10 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HIMS | SELL | 2023-03-01 | 2023-03-03 | $10.85 | $55.8M | -12.4% | +0.3% | -13.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.